β-keto-ester chemistry and ketolides.: Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides

被引:42
作者
Denis, A
Bretin, F
Fromentin, C
Bonnet, A
Piltan, G
Bonnefoy, A
Agouridas, C
机构
[1] Aventis Pharma, Med Chem, F-93235 Romainville, France
[2] Aventis Pharma, Chem, F-93235 Romainville, France
[3] Aventis Pharma, Core Res Funct, F-93235 Romainville, France
[4] Aventis Pharma, Antiinfect Dis Grp, F-93235 Romainville, France
关键词
D O I
10.1016/S0960-894X(00)00392-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effect of 2,3 modifications on the antibacterial activity of ketolides was evaluated by introducing substituents in position 2 and converting the C-1, C-2, C-3 beta-keto-ester into stable 2,3 enol-ether or 2,3 anhydro derivatives. Introduction of a fluorine in C-2. is beneficial with regard to the overall antibacterial spectrum whereas the enol-ether and 2,3 unsaturated compounds, as well as the bulky gem dimethyl or 2-chloro derivatives, are less active particularly against erythromycin resistant strains. A 2-fluoro ketolide derivative demonstrates good antibacterial activity and in vivo efficacy against multi-resistant Streptococcus pneumoniae. Compared to azithromycin against Haemophilus influenzae, this compound is equivalent in vitro and slightly more active in vivo. These results demonstrate that within the ketolide class, to retain good antibacterial activity, position needs to remain tetrahedral and tolerates only very small substituents such as fluorine. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2019 / 2022
页数:4
相关论文
共 9 条
  • [1] Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives):: A new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens
    Agouridas, C
    Denis, A
    Auger, JM
    Benedetti, Y
    Bonnefoy, A
    Bretin, F
    Chantot, JF
    Dussarat, A
    Fromentin, C
    D'Ambrières, SG
    Lachaud, S
    Laurin, P
    Le Martret, O
    Loyau, V
    Tessot, N
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) : 4080 - 4100
  • [2] Ketolides lack inducibility properties of MLSB resistance phenotype
    Bonnefoy, A
    Girard, AM
    Agouridas, C
    Chantot, JF
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 85 - 90
  • [3] Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens
    Denis, A
    Agouridas, C
    Auger, JM
    Benedetti, Y
    Bonnefoy, A
    Bretin, F
    Chantot, JF
    Dussarat, A
    Fromentin, C
    D'Ambrières, SG
    Lachaud, S
    Laurin, P
    Le Martret, O
    Loyau, V
    Tessot, N
    Pejac, JM
    Perron, S
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (21) : 3075 - 3080
  • [4] Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues
    Elliott, RL
    Pireh, D
    Griesgraber, G
    Nilius, AM
    Ewing, PJ
    Bui, MH
    Raney, PM
    Flamm, RK
    Kim, K
    Henry, RF
    Chu, DTW
    Plattner, JJ
    Or, YS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (10) : 1651 - 1659
  • [5] INOUE M, 1998, 38 INT C ANT AG CHEM
  • [6] MA Z, 1999, 39 INT C ANT AG CHEM
  • [7] OR YS, 1998, Patent No. 9809978
  • [8] Phan L.T., 1998, 38 INT C ANT AG CHEM
  • [9] PHAN LT, 1997, 37 INT C ANT AG CHEM